Follow
Vikas Pejaver
Title
Cited by
Cited by
Year
REVEL: an ensemble method for predicting the pathogenicity of rare missense variants
NM Ioannidis, JH Rothstein, V Pejaver, S Middha, SK McDonnell, ...
The American Journal of Human Genetics 99 (4), 877-885, 2016
17282016
Functional and Evolutionary Insights from the Genomes of Three Parasitoid Nasonia Species
JH Werren, S Richards, CA Desjardins, O Niehuis, J Gadau, ...
Science 327 (5963), 343-348, 2010
9282010
Inferring the molecular and phenotypic impact of amino acid variants with MutPred2
V Pejaver, J Urresti, J Lugo-Martinez, KA Pagel, GN Lin, HJ Nam, M Mort, ...
Nature communications 11 (1), 5918, 2020
4972020
Big data in public health: terminology, machine learning, and privacy
SJ Mooney, V Pejaver
Annual review of public health 39, 95-112, 2018
3642018
The structural and functional signatures of proteins that undergo multiple events of post‐translational modification
V Pejaver, WL Hsu, F Xin, AK Dunker, VN Uversky, P Radivojac
Protein Science 23 (8), 1077-1093, 2014
3512014
Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria
V Pejaver, AB Byrne, BJ Feng, KA Pagel, SD Mooney, R Karchin, ...
The American Journal of Human Genetics 109 (12), 2163-2177, 2022
143*2022
The comparative genomics and complex population history of Papio baboons
J Rogers, M Raveendran, RA Harris, T Mailund, K Leppälä, ...
Science Advances 5 (1), eaau6947, 2019
1392019
When loss-of-function is loss of function: assessing mutational signatures and impact of loss-of-function genetic variants
KA Pagel, V Pejaver, GN Lin, HJ Nam, M Mort, DN Cooper, J Sebat, ...
Bioinformatics 33 (14), i389-i398, 2017
722017
Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework
G Glusman, PW Rose, A Prlić, J Dougherty, JM Duarte, AS Hoffman, ...
Genome medicine 9, 1-10, 2017
582017
A survey-based analysis of the academic job market
JD Fernandes, S Sarabipour, CT Smith, NM Niemi, NM Jadavji, AJ Kozik, ...
Elife 9, e54097, 2020
57*2020
A predictive tool for identification of SARS-CoV-2 PCR-negative emergency department patients using routine test results
RP Joshi, V Pejaver, NE Hammarlund, H Sung, SK Lee, A Furmanchuk, ...
Journal of Clinical Virology 129, 104502, 2020
552020
Missense variant pathogenicity predictors generalize well across a range of function‐specific prediction challenges
V Pejaver, SD Mooney, P Radivojac
Human mutation 38 (9), 1092-1108, 2017
532017
Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges
R Daneshjou, Y Wang, Y Bromberg, S Bovo, PL Martelli, G Babbi, ...
Human mutation 38 (9), 1182-1192, 2017
472017
SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection
S Gombar, T Bergquist, V Pejaver, NE Hammarlund, K Murugesan, ...
Diagnostic Microbiology and Infectious Disease 100 (2), 115338, 2021
332021
The loss and gain of functional amino acid residues is a common mechanism causing human inherited disease
J Lugo-Martinez, V Pejaver, KA Pagel, S Jain, M Mort, DN Cooper, ...
PLoS computational biology 12 (8), e1005091, 2016
252016
Target site specificity and in vivo complexity of the mammalian arginylome
J Wang, VR Pejaver, GP Dann, MY Wolf, M Kellis, Y Huang, BA Garcia, ...
Scientific reports 8 (1), 16177, 2018
242018
Physicochemical sequence characteristics that influence S-palmitoylation propensity
KD Reddy, J Malipeddi, S DeForte, V Pejaver, P Radivojac, VN Uversky, ...
Journal of Biomolecular Structure and Dynamics 35 (11), 2337-2350, 2017
222017
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants
MS Cline, G Babbi, S Bonache, Y Cao, R Casadio, X de la Cruz, O Díez, ...
Human Mutation 40 (9), 1546-1556, 2019
192019
Assessment of methods for predicting the effects of PTEN and TPMT protein variants
V Pejaver, G Babbi, R Casadio, L Folkman, P Katsonis, K Kundu, ...
Human mutation 40 (9), 1495-1506, 2019
172019
Assessment of predicted enzymatic activity of α‐N‐acetylglucosaminidase variants of unknown significance for CAGI 2016
WT Clark, L Kasak, C Bakolitsa, Z Hu, G Andreoletti, G Babbi, Y Bromberg, ...
Human mutation 40 (9), 1519-1529, 2019
142019
The system can't perform the operation now. Try again later.
Articles 1–20